CCL2 and kidney disorder: A study by Srivastava et al. [12] has previously evaluated plasma biomarkers across diverse kidney diseases and found that sTNFR1, sTNFR2, YKL-40 MCP-1, and suPAR are associated with various kidney diseases like proliferative glomerulonephritis, non-proliferative glomerulopathy, advanced glomerulosclerosis, and diabetic kidney diseases, but the study has not evaluated the plasma biomarkers with MVI in kidney transplant recipients.